Dipexium Pharmaceuticals, Inc.'s Acting Chief Financial Officer just declared ownership of no shares of Dipexium Pharmaceuticals, Inc.

David Emerson Jorden, Dipexium Pharmaceuticals, Inc.'s Acting Chief Financial Officer, appears to have filed an empty initial statement of beneficial ownership. This form is usually filed as a prelude to a company officer either receiving options or buying company shares, so there may be more to come from Jorden.

Here is the filing.

To get notified when Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Dipexium Pharmaceuticals: Plx Pharma Hires Key Commercial Executives In Preparation For Future Launch Of Aspertec - Sept. 19, 2017

Auto Refresh

Feedback